Total Payments
$65,024
2024 Payments
$21.65
Companies
19
Transactions
135
Medicare Patients
3,707
Medicare Billing
$144,274
Payment Breakdown by Category
Consulting$49,801 (76.6%)
Other$10,800 (16.6%)
Travel$2,937 (4.5%)
Food & Beverage$1,487 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $49,801 | 53 | 76.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,800 | 3 | 16.6% |
| Travel and Lodging | $2,937 | 12 | 4.5% |
| Food and Beverage | $1,487 | 67 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LivaNova USA, Inc. | $49,801 | 53 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $14,345 | 27 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $184.67 | 13 | $0 (2018) |
| Medtronic, Inc. | $111.09 | 1 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $110.72 | 9 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $83.57 | 6 | $0 (2018) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $73.27 | 6 | $0 (2024) |
| United Therapeutics Corporation | $54.87 | 1 | $0 (2017) |
| PFIZER INC. | $48.01 | 4 | $0 (2018) |
| Daiichi Sankyo Inc. | $34.52 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.65 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($21.65) |
| 2023 | $4,200 | 6 | LivaNova USA, Inc. ($4,200) |
| 2022 | $14,700 | 11 | LivaNova USA, Inc. ($14,700) |
| 2021 | $10,905 | 17 | LivaNova USA, Inc. ($10,780) |
| 2020 | $16,361 | 13 | LivaNova USA, Inc. ($16,361) |
| 2019 | $3,360 | 7 | LivaNova USA, Inc. ($3,360) |
| 2018 | $13,043 | 47 | Actelion Pharmaceuticals US, Inc. ($12,298) |
| 2017 | $2,434 | 33 | Actelion Pharmaceuticals US, Inc. ($2,047) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.65 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/17/2023 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $1,260.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/12/2023 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/30/2023 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $560.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/10/2023 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $420.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/08/2023 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $420.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/07/2023 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $840.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/08/2022 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $3,220.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2022 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/13/2022 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $1,680.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/31/2022 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $420.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/29/2022 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/01/2022 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $560.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/03/2022 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/30/2022 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $420.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/28/2022 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $980.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/31/2022 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $1,540.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/05/2022 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $980.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/30/2021 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $980.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/30/2021 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $840.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2021 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $840.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2021 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Respiratory | ||||||
| 09/30/2021 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $840.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2021 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/30/2021 | LivaNova USA, Inc. | VNS - Vitaria (Device) | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,086 | 1,212 | $191,088 | $48,149 |
| 2022 | 19 | 1,946 | 2,224 | $213,999 | $60,866 |
| 2021 | 8 | 367 | 436 | $110,157 | $17,643 |
| 2020 | 9 | 308 | 333 | $104,779 | $17,616 |
Total Patients
3,707
Total Services
4,205
Medicare Billing
$144,274
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 220 | 220 | $59,229 | $10,872 | 18.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 59 | 98 | $29,280 | $9,763 | 33.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 67 | 95 | $17,490 | $6,059 | 34.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 54 | 55 | $18,030 | $5,551 | 30.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 34 | $16,985 | $4,918 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 36 | 43 | $6,155 | $2,535 | 41.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 29 | 29 | $4,371 | $2,365 | 54.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 279 | 324 | $10,772 | $1,893 | 17.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 58 | 58 | $6,655 | $821.62 | 12.3% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 34 | 36 | $3,002 | $693.16 | 23.1% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 14 | 14 | $2,511 | $663.05 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 12 | 12 | $946.37 | $615.24 | 65.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 58 | 58 | $11,114 | $557.96 | 5.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 54 | 54 | $1,381 | $293.97 | 21.3% |
| 93352 | Injection of x-ray contrast during ultrasound of heart | Facility | 2023 | 12 | 12 | $1,337 | $276.21 | 20.7% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 31 | 33 | $652.50 | $183.57 | 28.1% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 35 | 37 | $1,178 | $86.76 | 7.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 353 | 354 | $60,644 | $18,186 | 30.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 40 | 42 | $17,942 | $6,342 | 35.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 56 | 56 | $8,500 | $5,734 | 67.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 567 | 803 | $27,048 | $4,728 | 17.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 44 | 44 | $13,083 | $4,727 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 51 | 56 | $6,324 | $4,231 | 66.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 26 | 34 | $7,952 | $2,680 | 33.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 128 | 129 | $14,801 | $2,087 | 14.1% |
About Dr. Ron Oren, MD
Dr. Ron Oren, MD is a Cardiovascular Disease healthcare provider based in Naperville, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366422438.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ron Oren, MD has received a total of $65,024 in payments from pharmaceutical and medical device companies, with $21.65 received in 2024. These payments were reported across 135 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($49,801).
As a Medicare-enrolled provider, Oren has provided services to 3,707 Medicare beneficiaries, totaling 4,205 services with total Medicare billing of $144,274. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease, Cardiovascular Disease
- Location Naperville, IL
- Active Since 01/17/2006
- Last Updated 08/11/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1366422438
Products in Payments
- VNS - Vitaria (Device) $29,680
- VNS Therapy (Device) $20,121
- UPTRAVI (Drug) $6,218
- ENTRESTO (Drug) $184.67
- INTERSTIM (Device) $111.09
- XARELTO (Drug) $110.72
- PRADAXA (Drug) $83.57
- LifeVest (Device) $73.27
- ELIQUIS (Drug) $69.53
- Corlanor (Drug) $26.24
- NORTHERA (Drug) $25.91
- CardioMEMS HF System (Device) $20.73
- Welchol (Drug) $18.47
- Effient (Drug) $16.05
- PRALUENT ALIROCUMAB INJECTION (Biological) $15.51
- Edarbi (Drug) $14.57
- SYMBICORT (Drug) $13.73
- BRILINTA (Drug) $13.28
- ZONTIVITY (Drug) $13.10
- Definity (Drug) $12.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Naperville
Alan Brown, Md, MD
Cardiovascular Disease — Payments: $1.2M
Cardiovascular Disease $1.2M
Moeen Saleem, Md, MD
Cardiovascular Disease — Payments: $415,209
Cardiovascular Disease $415,209
Mark Goodwin, Md, MD
Cardiovascular Disease — Payments: $212,105
Cardiovascular Disease $212,105
Dr. Sujith Kalathiveetil, M.d, M.D
Cardiovascular Disease — Payments: $134,907
Cardiovascular Disease $134,907
Dr. Krishna Nagendran, Md, MD
Cardiovascular Disease — Payments: $96,761
Cardiovascular Disease $96,761
Dr. Aman Ali, M.d, M.D
Cardiovascular Disease — Payments: $50,248
Cardiovascular Disease $50,248